跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SEMAGLUTIDE INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SEMAGLUTIDE INJECTION
Authorized
STANDARD
SEMAGLUTIDE INJECTION
Aspen Pharmacare Canada Inc.
🇨🇦 Health Canada
Approval Date
Sep 4, 2026
Approval ID
18e0f9e403c12e14
Company
Aspen Pharmacare Canada Inc.
Type
Standard
Approval Details
Approval Id
18e0f9e403c12e14
Drug Approval Canada Name
SEMAGLUTIDE INJECTION
Product Name
SEMAGLUTIDE INJECTION
Status
Approved
Status Date
2026-08-25
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
PRESCRIPTION
Atc Original
A10BJ06 SEMAGLUTIDE
Aig Number
0159870002
Company Name
Aspen Pharmacare Canada Inc.
Company Address
2030 Bristol Circle, Suite 201 Oakville Ontario Canada L6H 0H2
Company Detail Path
/organization/aspen-pharmacare-canada-inc
Company Information
Pharmaceutical Company Name
Aspen Pharmacare Canada Inc.
Country Name
Canada
Province Name
Ontario
City Name
oakville,ontario,country_ca
Address
8-1155 North Service Rd W
Website
http://www.aspenpharma.com/
Active Ingredients
SEMAGLUTIDE
1.34 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Sep 4, 2026
Approval ID
18e0f9e403c12e14
Type
Standard
Back to Health Canada Approvals